ZA92729B - Pharmaceutical agent - Google Patents
Pharmaceutical agentInfo
- Publication number
- ZA92729B ZA92729B ZA92729A ZA92729A ZA92729B ZA 92729 B ZA92729 B ZA 92729B ZA 92729 A ZA92729 A ZA 92729A ZA 92729 A ZA92729 A ZA 92729A ZA 92729 B ZA92729 B ZA 92729B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102727A GB9102727D0 (en) | 1991-02-08 | 1991-02-08 | Pharmaceutical agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA92729B true ZA92729B (en) | 1992-11-25 |
Family
ID=10689748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA92729A ZA92729B (en) | 1991-02-08 | 1992-01-31 | Pharmaceutical agent |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1064809A (zh) |
| AP (1) | AP9200355A0 (zh) |
| AU (1) | AU1189392A (zh) |
| CA (1) | CA2060825A1 (zh) |
| GB (2) | GB9102727D0 (zh) |
| HU (1) | HUT60489A (zh) |
| IE (1) | IE920243A1 (zh) |
| IL (1) | IL100793A0 (zh) |
| MX (1) | MX9200532A (zh) |
| PT (1) | PT100097A (zh) |
| WO (1) | WO1992013853A1 (zh) |
| ZA (1) | ZA92729B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW297025B (zh) * | 1992-02-14 | 1997-02-01 | Squibb & Sons Inc | |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| PT3004138T (pt) | 2013-06-05 | 2024-06-18 | Bausch Health Ireland Ltd | Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos |
| LT3046584T (lt) | 2013-09-16 | 2017-10-10 | Astrazeneca Ab | Terapinės polimerinės nanodalelės ir jų gamybos būdai ir panaudojimas |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| NZ234854A (en) * | 1989-08-11 | 1993-02-25 | Ici Plc | Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof |
-
1991
- 1991-02-08 GB GB919102727A patent/GB9102727D0/en active Pending
-
1992
- 1992-01-27 IE IE024392A patent/IE920243A1/en unknown
- 1992-01-28 IL IL100793A patent/IL100793A0/xx unknown
- 1992-01-31 ZA ZA92729A patent/ZA92729B/xx unknown
- 1992-02-03 AP APAP/P/1992/000355A patent/AP9200355A0/en unknown
- 1992-02-05 AU AU11893/92A patent/AU1189392A/en not_active Abandoned
- 1992-02-05 WO PCT/GB1992/000214 patent/WO1992013853A1/en active Application Filing
- 1992-02-05 HU HU9200354A patent/HUT60489A/hu unknown
- 1992-02-05 GB GB9202377A patent/GB2252557A/en not_active Withdrawn
- 1992-02-06 PT PT100097A patent/PT100097A/pt not_active Application Discontinuation
- 1992-02-07 MX MX9200532A patent/MX9200532A/es unknown
- 1992-02-07 CA CA002060825A patent/CA2060825A1/en not_active Abandoned
- 1992-02-08 CN CN92101425A patent/CN1064809A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU1189392A (en) | 1992-09-07 |
| CA2060825A1 (en) | 1992-08-09 |
| CN1064809A (zh) | 1992-09-30 |
| MX9200532A (es) | 1992-08-01 |
| HUT60489A (en) | 1992-09-28 |
| GB9202377D0 (en) | 1992-03-18 |
| HU9200354D0 (en) | 1992-04-28 |
| GB2252557A (en) | 1992-08-12 |
| GB9102727D0 (en) | 1991-03-27 |
| IE920243A1 (en) | 1992-08-12 |
| IL100793A0 (en) | 1992-09-06 |
| PT100097A (pt) | 1993-04-30 |
| AP9200355A0 (en) | 1993-08-03 |
| WO1992013853A1 (en) | 1992-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL304317A1 (en) | Pharmaceutical agent | |
| GB9126354D0 (en) | Pharmaceutical agents | |
| IL102777A0 (en) | Pharmaceutical combination formulation | |
| PL304508A1 (en) | Pharmaceutical agent | |
| GB9108080D0 (en) | Pharmaceutical composition | |
| AP9200356A0 (en) | Pharmaceutical composition | |
| GB9114950D0 (en) | Pharmaceutical formulation | |
| HU9300804D0 (en) | Pharmaceutical preparatives | |
| ZA92729B (en) | Pharmaceutical agent | |
| GB9216061D0 (en) | Pharmaceutical combination formulation | |
| GB9000241D0 (en) | Pharmaceutical use | |
| GB2252497B (en) | Pharmaceutical composition | |
| PL297548A1 (en) | Pharmaceutical agent | |
| GB9104123D0 (en) | Pharmaceutical agent | |
| GB9104124D0 (en) | Pharmaceutical agent | |
| GB9111477D0 (en) | Pharmaceutical composition | |
| GB9115107D0 (en) | Pharmaceutical agents | |
| GB9113622D0 (en) | Medicinal agents | |
| ZA924842B (en) | Asialoglycoprotein-conjugated medicinal agent | |
| GB9113850D0 (en) | New pharmaceutical use | |
| GB9123202D0 (en) | New pharmaceutical use | |
| GB9113943D0 (en) | New pharmaceutical use | |
| GB9104307D0 (en) | New pharmaceutical use | |
| GB9104269D0 (en) | New pharmaceutical use | |
| GB9104306D0 (en) | New pharmaceutical use |